VRAX Stock Analysis: Buy, Sell, or Hold?
VRAX - Virax Biolabs Group Limited Ordinary Shares
$0.16
0.00 (2.95%)
▲
5d:
-7.08%
30d:
-27.98%
90d:
-54.32%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Get Alerted When VRAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VRAX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VRAX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VRAX is currently trading at $0.16, which is considered oversold relative to its 30-day fair value range of $0.18 to $0.22.
Technical Outlook: Technically, VRAX is in a strong downtrend. Immediate support is located at $0.15, while resistance sits at $0.21.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+1783.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VRAX is in a strong downtrend. Immediate support is located at $0.15, while resistance sits at $0.21.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+1783.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.18 -
$0.22
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1783.2% below Wall St target ($3.00)
- CAUTION: Recommendation downgraded due to -7.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.18 -
$0.22
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.15
Resistance Level
$0.21
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Wall Street Target
$3.00
(+1783.2%)
Revenue Growth (YoY)
-67.5%
Share & Embed Analysis
Last updated: March 30, 2026 2:03 PM ET
Data refreshes hourly during market hours. Next update: 3:03 PM
Data refreshes hourly during market hours. Next update: 3:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VRAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 48 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 48 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 49 HOLD |
